The concept of the RVC Biopharmaceutical Investments Ltd. (RVC Biofund Ltd.) was approved by the Board of Directors of RVC, in June, 2010. The RVC Biofund Ltd. began its operations in early 2011.
The need to create the RVC Biofund Ltd. has been brought about by the low fraction (less than 1%) of domestic medications on the Russian pharmaceutical market. The lack of an infrastructure for developing pharmaceutical and medical startups in Russia necessitates the expenditure of a significant fraction (50 to 80%) of Russian investment resources to pay for foreign services. The strategic goal of RVC Biofund Ltd. is to assist in creating a geographically distributed cluster of innovative and infrastructural (bio)pharmaceutical companies in Russia by introducing the market methods of investment and financial cooperation into Russian practice.
In this connection, RVC Biofund Ltd. invests in service companies in the cluster and in biotechnological startups, and also facilitates the creation of an ecosystem for the generation and growth of the largest possible number of biotechnological projects. The Fund focuses primarily on supporting innovative biopharmaceutical companies and service companies that offer contract laboratory, information-analytical, and consulting services to companies in the biotechnological sectors and to the pharmaceutical and medical industry.
The mission of Biofund is ensuring the implementation of the following objectives:
The prepared food media planned for production consist of multi-component complex, liquid, semiliqui
Creation of a specialized radiation processing center in the Vladimirsk Region in the Stavrovo Techn
Creation of a network of medical centers in Russia for developing personalized medicine, based on th
A company rendering a broad spectrum of services in selecting, processing, characterizing, storing,